Bladex, the Panama-based bank focused on financing foreign trade across Latin America and the Caribbean, posted third-quarter results that reflect ongoing strength in regional trade activity. The bank continues to grow its commercial portfolio as demand from financial institutions and corporations increases. A 15% rise in net profit and a 20% increase in revenues point to sustained momentum, while higher impairment losses suggest a more measured approach to credit in the current environment. For investors, the report provides insight into Latin American trade flows, net interest margin trends, and the bank’s ability to manage loan growth alongside asset quality.
Bladex announced net profit of $63.2 million for the third quarter ended September 30, 2026, a 15% increase from $55.0 million in 3Q25. EPS was $1.48, unchanged from the prior-year period and down 16% sequentially from $1.77 in 2Q26. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Total revenues were $99.1 million, up 20% year over year. Net interest income rose 18% to $79.8 million. Net fees and commissions grew 16% year over year to $16.3 million, though they declined 30% from the prior quarter. Gains on financial instruments increased to $3.0 million.
Operating expenses increased 20% year over year to $25.6 million, while impairment losses on financial instruments rose to $10.4 million from $6.5 million a year earlier. Return on average equity was 14.2%, and the net interest margin was 2.30%. Total assets reached $16.48 billion, up 32% year over year.
Bladex reported results after the market close on October 26, 2026, with a conference call scheduled for the following morning. The bank’s market capitalization stood at approximately $2.07 billion, down from $2.31 billion in the prior quarter. The headline figures showed double-digit revenue and profit growth, which were generally supportive, but the sequential decline in EPS, a drop in fee income, and elevated impairment losses gave investors reasons for caution. Net interest margin remained relatively stable, indicating the bank has managed rate pressures without significant deterioration.
Looking ahead, several themes will shape Bladex’s trajectory. Loan and credit portfolio growth has been a key earnings driver, and sustaining that momentum will depend on continued demand for trade finance across Latin America and the Caribbean. Credit quality also merits attention, as impairment losses rose year over year and the allowance for loan losses relative to the credit portfolio is worth monitoring. The net interest margin will remain a focal point as interest rates potentially shift, while the efficiency ratio will show whether the bank can scale without letting costs erode returns. The $0.6875 per-share quarterly dividend reaffirms management’s commitment to returning capital to shareholders.
When reviewing quarterly results like these, I find it helpful to cross-check performance metrics and peer comparisons with Tickeron’s AI tools. This approach adds another layer of context to the reported numbers and helps identify how Bladex stacks up against broader sector trends without relying solely on manual review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BLX saw its Momentum Indicator move below the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In 35 of the 80 cases, the stock moved further down in the following days. The odds of a decline are at 44%.
The Moving Average Convergence Divergence Histogram (MACD) for BLX turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 18 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 35%.
BLX moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.
The RSI Indicator entered the oversold zone -- be on the watch for BLX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where BLX advanced for three days, in 241 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
BLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 12 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock better than average.
The Tickeron SMR rating for this company is 21 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. BLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.065) is normal, around the industry mean (1.265). P/E Ratio (8.231) is within average values for comparable stocks, (13.523). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (1.194). Dividend Yield (0.055) settles around the average of (0.036) among similar stocks. BLX's P/S Ratio (6.101) is slightly higher than the industry average of (3.751).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks